| Literature DB >> 14726377 |
Ileana M Cristea1, Simon J Gaskell, Anthony D Whetton.
Abstract
The recent sequencing of a number of genomes has raised the level of opportunities for studies on proteins. This area of research has been described with the all-embracing term, proteomics. In proteomics, the use of mass spectrometric techniques enables genomic databases to be used to establish the identity of proteins with relatively little data, compared to the era before genome sequencing. The use of related analytical techniques also offers the opportunity to gain information on regulation, via posttranslational modification, and potential new diagnostic and prognostic indicators. Relative quantification of proteins and peptides in cellular and extracellular material remains a challenge for proteomics and mass spectrometry. This review presents an analysis of the present and future impact of these proteomic technologies with emphasis on relative quantification for hematologic research giving an appraisal of their potential benefits.Mesh:
Substances:
Year: 2004 PMID: 14726377 DOI: 10.1182/blood-2003-09-3295
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113